Gary Taylor

Stock Analyst at TD Cowen

(2.56)
# 2,311
Out of 4,966 analysts
146
Total ratings
51.55%
Success rate
0.5%
Average return

Stocks Rated by Gary Taylor

Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $29.21
Upside: +43.79%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $8.33
Upside: +50.06%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $1.28
Upside: +56.25%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $303.66
Upside: -11.74%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $16.36
Upside: -20.54%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $403.96
Upside: +8.92%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $309.87
Upside: +96.53%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $29.04
Upside: +206.47%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $180.83
Upside: +109.04%
Universal Health Services
Jul 26, 2024
Maintains: Hold
Price Target: $183$220
Current: $181.58
Upside: +21.16%
Maintains: Hold
Price Target: $139$150
Current: $137.76
Upside: +8.89%
Maintains: Buy
Price Target: $101$91
Current: $22.96
Upside: +296.34%
Maintains: Outperform
Price Target: $30$26
Current: $23.04
Upside: +12.85%
Upgrades: Outperform
Price Target: $39$35
Current: $22.69
Upside: +54.25%
Maintains: Outperform
Price Target: $564$585
Current: $318.65
Upside: +83.59%
Maintains: Market Perform
Price Target: $3$6
Current: $16.66
Upside: -63.99%
Maintains: Outperform
Price Target: $10$8
Current: $5.48
Upside: +45.99%
Upgrades: Outperform
Price Target: $242$329
Current: $300.87
Upside: +9.35%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.62
Upside: +14.50%
Initiates: Market Perform
Price Target: $17
Current: $3.83
Upside: +343.86%
Downgrades: Underweight
Price Target: $28$20
Current: $184.33
Upside: -89.15%
Maintains: Neutral
Price Target: $33$20
Current: $17.21
Upside: +16.21%
Downgrades: Underweight
Price Target: n/a
Current: $2.76
Upside: -